REFERRED JOURNAL ARTICLES:
1. Song HJ, Yin W, Zeng Q, Jia HZ, Li L, Liu XD, Mu LY, Wang R*. Hemokinins modulate endothelium function and promote angiogenesis through neurokinin-1 receptor. Int J Biochem Cell. 2012: 44(9): 1410-1421.
2. Song HJ, Kai M, Liu XD, Yin W, Zeng Q, Yao XJ, Wang R*. A new chiral 2-(ethylthio)-thiazolone analogue shows strong antitumor activities by inducing cancer cell apoptosis and inhibiting angiogenesis. Anti-cancer Drug. 2012; 23:914-922.
3.Dai X, Song HJ, Cui, SG, Wang T, Liu Q, Wang R*. The stimulative effects of endogenous opioids on endothelial cell proliferation, migration and angiogenesis in vitro. Eur J Pharmacol. 2010: 628(1-3): 42-50.
4.Liu XD, Deng LJ, Song HJ, Jia HZ, Wang R*. Asymmetric Aza-Mannich addition: synthesis of modified chiral 2-(Ethylthio)-thiazolone derivatives with anticancer potency. Org. Lett. 2011: 13: 1494–1497.
5.Mou, L.;Kang, Y.;Zhou, Y.;Zeng, Q.;Song, HJ.;Wang, R*. Neurokinin-1 receptor directly mediates glioma cell migration by up-regulation of matrix metalloproteinase-2 (MMP-2) and membrane type 1-matrix metalloproteinase (MT1-MMP). J Biol Chem. 2013; 288(1):306-318.

CONFERENCES:
1.Song HJ, Hua ZJ, Kong ZQ, Zhang W, Wang R*. Hemokinin-1 induce migration, proliferation, adhesion, tube formation of endothelium cell and angiogenesis in chicken choriallantoic membrane. 11th Chinese International Peptide Symposium. Abstract and Poster.

PATENTS:
1.Wang R, Liu XD, Song HJ. The Preparation and Utility of New Anti-cancer Leading Compounds – A Series of Chiral 2, 4-Disubstituted Thiazolone Derivatives. Chinese Patent. Patent number: (201110283640.4).
2.Wang R, Lin L, Song HJ. The Preparation and Utility of New Anti-cancer Leading Compounds – A Series of Chiralγ-hydroxy propionic acid derivatives. Chinese Patent. Patent number: (201110184445.6).